O Shaughnessy Asset Management LLC decreased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 45.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,890 shares of the insurance provider's stock after selling 2,375 shares during the quarter. O Shaughnessy Asset Management LLC's holdings in Humana were worth $733,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in HUM. Pinnacle Wealth Management Advisory Group LLC raised its position in Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after acquiring an additional 37 shares during the last quarter. Atlas Brown Inc. raised its position in shares of Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after purchasing an additional 38 shares during the last quarter. Mather Group LLC. lifted its stake in Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after buying an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC grew its holdings in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock valued at $53,000 after buying an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. increased its position in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after buying an additional 43 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms recently commented on HUM. Barclays increased their price objective on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. Cantor Fitzgerald restated a "neutral" rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Finally, Mizuho boosted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $288.60.
View Our Latest Analysis on Humana
Humana Stock Down 1.9 %
HUM traded down $5.58 during trading hours on Monday, reaching $289.46. 120,785 shares of the stock traded hands, compared to its average volume of 1,635,424. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm's fifty day simple moving average is $265.55 and its two-hundred day simple moving average is $270.35. The company has a market cap of $34.94 billion, a price-to-earnings ratio of 29.09, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is presently 35.58%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
